Valuation: InMode Ltd.

Market Cap 871M 764M 707M 651M 1.23B 83.35B 1.26B 8.43B 3.31B 40.93B 3.27B 3.2B 141B P/E 2026 *
13.1x
P/E 2027 * 11.9x
Enterprise Value 871M 764M 707M 651M 1.23B 83.35B 1.26B 8.43B 3.31B 40.93B 3.27B 3.2B 141B EV / Sales 2026 *
2.35x
EV / Sales 2027 * 2.3x
Free-Float
60.55%
Yield 2026 *
-
Yield 2027 * -
1 day-1.42%
1 week+2.96%
Current month+2.39%
1 month+10.32%
3 months+5.87%
6 months+6.62%
Current year+1.91%
1 week 14.4
Extreme 14.4
15.37
1 month 13.21
Extreme 13.21
15.37
Current year 12.72
Extreme 12.72
16.67
1 year 12.72
Extreme 12.72
16.74
3 years 12.72
Extreme 12.72
48.25
5 years 12.72
Extreme 12.72
99.27
10 years 6.53
Extreme 6.53
99.27
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 02/01/2008
Chief Executive Officer 73 02/01/2008
Director of Finance/CFO 41 19/05/2026
Director TitleAgeSince
Chairman 73 02/01/2008
Director/Board Member 59 07/08/2019
Chairman 67 05/05/2026
Date Insider Type Main position Quantity % Market Cap.
05-19Other

Chief Financial Officer

26,733 0.0422%
05-19Other

Chairman

0 0%
03-18Other

Chairman

10,000 0.0158%
Change 5-day change 1-year change 3-year change Capi.($)
-1.42%+2.96%+1.56%-66.69% 871M
+0.58%+2.99%+25.09%+0.51% 196B
-4.40%-9.00%-24.70%+9.85% 144B
-0.73%+2.46%+0.62%-17.28% 142B
-4.32%-6.07%-59.22%-19.76% 66.37B
-2.26%-5.35%+14.65%-3.89% 52.85B
-3.36%-3.09%-25.72%-33.90% 45.22B
+0.54%+2.62%+12.07%+12.38% 37.86B
+0.09%-0.07%+23.17%+38.36% 36.64B
-4.99%-4.25%-16.54%-24.06% 29.71B
Average -2.04%+0.30%-4.90%-10.45% 75.18B
Weighted average by Cap. -1.76%-0.32%-2.73%-3.83%

Financials

2026 *2027 *
Net sales 370M 325M 301M 277M 523M 35.44B 534M 3.58B 1.41B 17.4B 1.39B 1.36B 60.1B 379M 332M 308M 283M 536M 36.27B 546M 3.67B 1.44B 17.81B 1.42B 1.39B 61.52B
Net income 72.86M 63.91M 59.19M 54.46M 103M 6.97B 105M 705M 277M 3.42B 274M 268M 11.83B 78.41M 68.77M 63.69M 58.61M 111M 7.5B 113M 759M 298M 3.69B 294M 288M 12.73B
Net Debt - -
Logo InMode Ltd.
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Employees
660
Date Price Change Volume
14/07/26 $14.96 -1.25% 111,543
13/07/26 $15.15 -0.85% 693,078
10/07/26 $15.28 +1.80% 823,376
09/07/26 $15.01 +3.80% 1,684,399
08/07/26 $14.46 -0.55% 450,401
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
15.15USD
Average target price
15.33USD
Spread / Average Target
+1.21%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INMD Stock